FTC Secures $7B Express Scripts Settlement on Insulin Pricing — Caremark and Optum Next

Summary: FTC settled with Express Scripts over insulin pricing manipulation. Express Scripts pushed manufacturers to compete on rebate size rather than net price, retained inflated rebates. Expected savings: $7 billion over 10 years in out-of-pocket insulin costs. Caremark and Optum face identical lawsuits. Congress passed H.R. 7148 delinking PBM compensation from drug price in Medicare Part D.